Lennart Bergfeldt

Prof. Lennart Bergfeldt


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2005 in Heart
Verified
Journal Article
Open access
PDF file
Thomas KahanThomas Kahan
Thomas Kahan
LBLennart Bergfeldt
Lennart Bergfeldt
The presence of LV hypertrophy is a strong independent risk factor for future cardiac events and all cause mortality.1 The risk for sudden cardiac death is increased in subjects with LV hypertrophy, independent of the aetiology, and this event occurs also in individuals with no or only mild prior symptoms related to cardiovascular disease. Intense animal and human research has identified some common features and provided a framework within which some crucial components can be explained. Thus, whether the focus is haemodynamic or electrophysiologic, there seems to be consensus as to the initiation of a fetal-like gene programme in myocardial hypertrophy.2, 3 The insights into its consequences can be applied in the clinical management of individual patients.

5 January 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
ATAmar Taha
Amar Taha
SNSusanne J. Nielsen
Susanne J. Nielsen
LBLennart Bergfeldt
Lennart Bergfeldt
AAAnders Ahlsson
Anders Ahlsson
LFLeif Friberg
Leif Friberg
AJAnders Jeppsson
Anders Jeppsson
Background: The long‐term impact of new‐onset postoperative atrial fibrillation (POAF) after coronary artery bypass grafting and the benefit of early‐initiated oral anticoagulation (OAC) in patients with POAF are uncertain. Methods and Results: All patients who underwent coronary artery bypass grafting without preoperative atrial fibrillation in Sweden from 2007 to 2015 were included in a population‐based study using data from 4 national registries: SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence‐based Care in Heart Disease Evaluated According to Recommended Therapies), National Patient Registry, Dispensed Drug Registry, and Cause of Death Registry. POAF was defined as any new‐onset atrial fibrillation during the first 30 postoperative days. Cox regression models (adjusted for age, sex, comorbidity, and medication) were used to assess long‐term outcome in patients with and without POAF, and potential associations between early‐initiated OAC and outcome. In a cohort of 24 523 patients with coronary artery bypass grafting, POAF occurred in 7368 patients (30.0%), and 1770 (24.0%) of them were prescribed OAC within 30 days after surgery. During follow‐up (median 4.5 years, range 0‒9 years), POAF was associated with increased risk of ischemic stroke (adjusted hazard ratio [aHR] 1.18 [95% CI, 1.05‒1.32]), any thromboembolism (ischemic stroke, transient ischemic attack, or peripheral arterial embolism) (aHR 1.16, 1.05‒1.28), heart failure hospitalization (aHR 1.35, 1.21‒1.51), and recurrent atrial fibrillation (aHR 4.16, 3.76‒4.60), but not with all‐cause mortality (aHR 1.08, 0.98‒1.18). Early initiation of OAC was not associated with reduced risk of ischemic stroke or any thromboembolism but with increased risk for major bleeding (aHR 1.40, 1.08‒1.82). Conclusions: POAF after coronary artery bypass grafting is associated with negative prognostic impact. The role of early OAC therapy remains unclear. Studies aiming at reducing the occurrence of POAF and its consequences are warranted.

1 November 2015 in The American Journal of Medicine
Verified
Journal Article
Closed access
EKEva Klingberg
Eva Klingberg
BSBente Grüner Sveälv
Bente Grüner Sveälv
MTMargareta Scharin Täng
Margareta Scharin Täng
OBOdd Bech-Hanssen
Odd Bech-Hanssen
HFHelena Forsblad-d´Elia
Helena Forsblad-d´Elia
LBLennart Bergfeldt
Lennart Bergfeldt

12 August 2013 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
HFHelena Forsblad-d´Elia
Helena Forsblad-d´Elia
HWHanna Wallberg
Hanna Wallberg
EKEva Klingberg
Eva Klingberg
HCHans Carlsten
Hans Carlsten
LBLennart Bergfeldt
Lennart Bergfeldt
Cardiac conduction disturbances are common in spondyloarthropathies such as ankylosing spondylitis (AS). Whether their occurrence can be linked to signs and symptoms of rheumatic disease activity is an unsettled issue addressed in this study.

28 February 2021 in Epilepsy Currents
Verified
Journal Article
Open access
PDF file
JFJacqueline A. French
Jacqueline A. French
EPEmilio Perucca
Emilio Perucca
JSJosemir W. Sander
Josemir W. Sander
LBLennart Bergfeldt
Lennart Bergfeldt
MBMichel Baulac
Michel Baulac
TWTimothy E. Welty
Timothy E. Welty

1 July 2006 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
ARAigars Rubulis
Aigars Rubulis
JJJens Jensen
Jens Jensen
GLGunilla Lundahl
Gunilla Lundahl
JTJari Tapanainen
Jari Tapanainen
LBLennart Bergfeldt
Lennart Bergfeldt
Epidemiological studies show that left ventricular hypertrophy (LVH) and hypertension (HT) in coronary artery disease increases the risk for cardiovascular events including sudden cardiac death (SCD). According to experimental studies, myocardial hypertrophy is associated both with altered electrophysiological properties (including prolonged repolarization) and increased vulnerability to ischemia. However, human data to support a repolarization-related mechanism for the increased SCD risk has not been provided. We therefore studied 187 patients undergoing three-dimensional vectorcardiographic monitoring during coronary angioplasty. Eight parameters reflecting different aspects of ventricular repolarization were used: 1) the ST segment (ST-VM and STC-VM), 2) the T vector (QRS-T angle, Televation, and Tazimuth), and 3) the T vector loop (Tavplan, Teigenv, and Tarea). Data collection was performed at rest and at the time of maximum ischemia during coronary occlusion. The patients were divided into three groups: 33 patients with ECG signs of LVH (18 with HT), 54 with HT but without LVH signs, and 100 patients with neither. Coronary artery disease patients with LVH not only had the most abnormal baseline repolarization (as expected) but also a significantly more pronounced repolarization response during coronary occlusion, whereas HT patients had mean parameter values between LVH patients and those without neither HT nor LVH signs. Because there is a relation between increased SCD risk and repolarization disturbances in various clinical settings, the results of the present study are in agreement with animal data and epidemiological observations, although other factors than disturbed repolarization might be of importance.